Related Experiment Videos
[Butalamine hydrochloride. A new vasoactive substance]
Fortschritte Der Medizin
|April 15, 1976
Summary
Adrevil enhances blood flow and oxygen supply to diseased areas without impacting the cardiovascular system. This drug effectively treats painful, inflammatory, and proliferative conditions in ischemic regions with low toxicity.
Area of Science:
- Pharmacology
- Vascular Biology
- Pain Management
Context:
- Ischemic conditions impair local blood flow and oxygenation.
- Inflammatory and proliferative processes exacerbate tissue damage in ischemia.
- Current treatments may have cardiovascular side effects or limited efficacy.
Purpose:
- To evaluate the efficacy and safety of Adrevil.
- To investigate Adrevil's novel mechanism of action on blood flow.
- To assess its impact on pain, inflammation, and proliferation in ischemic tissues.
Summary:
- Adrevil stimulates blood flow and improves oxygen supply to diseased vascular areas via a new mode of action.
- It possesses antiphlogistic, analgetic, and local anesthetic properties beneficial for ischemic conditions.
- Demonstrated effectiveness at low doses with very low toxicity and no observed teratogenic effects in animal studies.
Impact:
- Adrevil presents a promising therapeutic agent for a wide range of indications related to vascular compromise.
- Its unique pharmacological profile offers a potentially safer alternative for managing ischemic pain and inflammation.
- Further clinical studies are warranted to confirm its therapeutic potential in human subjects.